Selective serotonin reuptake inhibitors (SSRIs) learning module - main section

2. Class members and licensed uses

Consult the summary of product characteristics for details of authorised indications of each SSRI.

SSRIs: Approved names, common proprietary names and licensed indications

  Citalopram Escital-opram
(enantiomer of citalopram)
Fluoxetine Fluvoxamine Paroxetine Sertraline
Common proprietory names Cipramil Cipralex Prozac Faverin Seroxat Lustral
Depressive illness Tickbox Tickbox Tickbox Tickbox Tickbox Tickbox
Generalised anxiety disorder   Tickbox     Tickbox  
Obsessive–compulsive disorder   Tickbox Tickbox Tickbox Tickbox Tickbox
Panic disorder with or without agoraphobia Tickbox Tickbox     Tickbox Tickbox
Social anxiety disorder (social phobia)   Tickbox     Tickbox Tickbox
Post-traumatic stress disorder         Tickbox Tickbox
Bulimia nervosa     Tickbox      

Antidepressants in other classes may also inhibit reuptake of serotonin, but only SSRIs are discussed here.

Only the following SSRIs are licensed for children and adolescents:

  • Fluoxetine for the treatment of moderate to severe major depressive episode (in combination with psychological therapy) in children aged over eight years and adolescents
  • Fluvoxamine for the treatment of obsessive–compulsive disorder in children aged over eight years and adolescents
  • Sertraline for the treatment of obsessive–compulsive disorder in children aged over six years and adolescents.

Page 3 of 29

Page last modified: 17 February 2015